Tipsheet
What matters at India’s listed companies
Concalls · Refractories · Small cap

IFGL pauses ₹300-350 cr Odisha plant, pushes Monocon UK breakeven to FY27 end

Management dropped a firm FY28 target for its greenfield expansion, sending it to the board for review. The UK unit's path to profit also slipped after losing a key customer.

1 earlier story on IFGL Refractories Ltd.
Mkt cap₹1,424 cr
P/E41.03×
ROE3.88%
Debt / eq.0.18
Div yld1.09%
₹1,904 cr FY26 consolidated revenue, up 14% year-on-year.

What's new

  • IFGL has deferred the FY28 completion target for its ₹300-350 cr Khurda greenfield project, sending the timeline back to the board.
  • Monocon UK's breakeven target moved to Q4 FY27 after losing a high-margin customer due to a plant closure.
  • Consolidated EBITDA margin compressed to 7.7% despite 14% revenue growth, though the US business recovered to double-digit margins.

Why this matters

Two firm growth milestones are now off the table. For a micro-cap, that changes the capital-allocation timeline. The domestic business is carrying the load, with India's 20% revenue expansion driving the entire 14% top-line growth. The international portfolio is the weak link.

What we're watching

  • The new timeline for the Khurda plant after the board's review.
  • Whether Monocon UK can stabilize without the lost high-margin customer.
  • The pace of India revenue growth in FY27 to see if it can offset the delays abroad.

The full read

IFGL Refractories is hitting pause on two fronts. The ₹300-350 crore greenfield plant in Khurda, Odisha, no longer has a firm FY28 completion target. Management has sent the project pace back to the board for review. Separately, the Monocon UK subsidiary pushed its breakeven to Q4 FY27 after losing a high-margin customer to a plant closure. These are the material changes in the June concall. On the operational side, the core numbers were solid: consolidated revenue hit ₹1,904 crore on 14% growth, powered by a 20% jump in Indian sales. The US business recovered to double-digit EBITDA margins. But consolidated EBITDA margin slipped to 7.7%, and the international portfolio is now the weak link. Management still guides for double-digit revenue growth in FY27. The open question is whether India's momentum can offset the delays abroad.

Questions answered

Why did IFGL defer the Khurda plant timeline?
Management pulled back from a firm FY28 completion date and sent the project schedule to the board for review. The filing provides no specific reason for the change, such as cost overruns or permitting issues.
What caused the delay in Monocon UK's breakeven?
The UK subsidiary lost a key high-margin customer after that customer closed a plant. As a result, the breakeven target shifted from an earlier timeline to the final quarter of FY27.
How did the different business segments perform in FY26?
Domestic India revenue grew 20%, driving overall top-line growth to 14%. The US business recovered to double-digit EBITDA margins, but the consolidated EBITDA margin for the group compressed to 7.7%.
What is management's growth outlook for FY27?
Management projected continued double-digit revenue growth for the next fiscal year. This guidance was given alongside the disclosures of delayed expansion plans and weaker UK performance.
Mentioned: ₹300-350 cr Khurda greenfield · Monocon UK · Q4 FY27 breakeven
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

  1. 2 Jun 2026 · 6:34 PM IST IFGL pauses ₹300-350 cr Odisha plant, pushes Monocon UK breakeven to FY27 end
  2. 2d ago IFGL's capex bill is half its market value. The topline has to keep up.